1. Home
  2. VTMX vs TVTX Comparison

VTMX vs TVTX Comparison

Compare VTMX & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTMX
  • TVTX
  • Stock Information
  • Founded
  • VTMX 1998
  • TVTX 2008
  • Country
  • VTMX Mexico
  • TVTX United States
  • Employees
  • VTMX N/A
  • TVTX N/A
  • Industry
  • VTMX
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTMX
  • TVTX Health Care
  • Exchange
  • VTMX Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • VTMX 2.2B
  • TVTX 1.8B
  • IPO Year
  • VTMX 2023
  • TVTX N/A
  • Fundamental
  • Price
  • VTMX $24.46
  • TVTX $21.98
  • Analyst Decision
  • VTMX Buy
  • TVTX Strong Buy
  • Analyst Count
  • VTMX 2
  • TVTX 12
  • Target Price
  • VTMX $33.50
  • TVTX $30.08
  • AVG Volume (30 Days)
  • VTMX 246.4K
  • TVTX 1.9M
  • Earning Date
  • VTMX 02-18-2025
  • TVTX 02-20-2025
  • Dividend Yield
  • VTMX 2.91%
  • TVTX N/A
  • EPS Growth
  • VTMX N/A
  • TVTX N/A
  • EPS
  • VTMX 0.25
  • TVTX N/A
  • Revenue
  • VTMX $252,327,122.00
  • TVTX $233,175,000.00
  • Revenue This Year
  • VTMX N/A
  • TVTX $62.88
  • Revenue Next Year
  • VTMX $9.13
  • TVTX $57.60
  • P/E Ratio
  • VTMX $9.15
  • TVTX N/A
  • Revenue Growth
  • VTMX 17.65
  • TVTX 60.55
  • 52 Week Low
  • VTMX $23.22
  • TVTX $5.12
  • 52 Week High
  • VTMX $41.44
  • TVTX $25.29
  • Technical
  • Relative Strength Index (RSI)
  • VTMX 37.01
  • TVTX 53.52
  • Support Level
  • VTMX $24.28
  • TVTX $22.48
  • Resistance Level
  • VTMX $27.24
  • TVTX $23.69
  • Average True Range (ATR)
  • VTMX 0.86
  • TVTX 1.22
  • MACD
  • VTMX -0.25
  • TVTX -0.02
  • Stochastic Oscillator
  • VTMX 5.10
  • TVTX 41.10

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is a real estate company dedicated to the development and leasing of industrial buildings and distribution centers in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenues is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: